Olema Pharmaceuticals Inc (OLMA) Ownership

$23.81

$1.4 (6.25%)
Last update: 03:49 AM EST
Day's range
$22.03
Day's range
$24

Olema Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 5.56 M $139.08 M   17.71% 6.49%
VANGUARD GROUP INC 01/29/2026 3.56 M $89.03 B   11.39% 4.15%
SIREN, L.L.C. 02/13/2026 3.30 M $82.52 M   100.00% 3.85%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 3.21 M $80.22 M   0.00% 3.74%
FRANKLIN RESOURCES INC 02/11/2026 2.48 M $61.92 M   -17.77% 2.89%
STATE STREET CORP 02/13/2026 1.88 M $47.11 M   72.32% 2.20%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.26 M $31.44 B   -1.45% 1.47%
02/13/2026 1.23 M $30.87 B   100.00% 1.44%
CITADEL ADVISORS LLC 02/17/2026 1.20 M $30.01 B   -2.96% 1.40%
SAMLYN CAPITAL, LLC 02/17/2026 1.07 M $26.74 M   100.00% 1.25%
JENNISON ASSOCIATES LLC 01/30/2026 964.00 K $24.10 M   100.00% 1.12%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 958.64 K $23.97 M   -9.95% 1.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/17/2026 953.60 K $23.84 M   11.66% 1.11%
GOLDMAN SACHS GROUP INC 02/10/2026 817.89 K $20.45 B   1.74% 0.95%
CANDRIAM S.C.A. 02/13/2026 679.48 K $16.99 M   -45.63% 0.79%
VIVO CAPITAL, LLC 02/13/2026 671.84 K $16.80 M   -55.38% 0.78%
MORGAN STANLEY 02/13/2026 665.80 K $16.65 M   -57.21% 0.78%
FIRST TURN MANAGEMENT, LLC 02/13/2026 617.71 K $15.44 M   100.00% 0.72%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 569.00 K $14.23 M   100.00% 0.66%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 502.57 K $12.60 M   -69.29% 0.59%
MILLENNIUM MANAGEMENT LLC 02/17/2026 498.49 K $12.46 M   50.39% 0.58%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 488.90 K $12.22 M   100.00% 0.57%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/14/2026 447.05 K $11.18 M   83.16% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 407.14 K $10.18 M   3.04% 0.47%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 404.00 K $10.10 M   100.00% 0.47%
TWO SIGMA INVESTMENTS, LP 02/17/2026 393.66 K $9.84 M   259.42% 0.46%
MARSHALL WACE, LLP 02/13/2026 360.39 K $9.01 M   100.00% 0.42%
SQUAREPOINT OPS LLC 02/13/2026 328.68 K $8.22 M   2,232.55% 0.38%
UBS GROUP AG 01/29/2026 293.56 K $7.34 M   -75.34% 0.34%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 02/12/2026 281.69 K $7.04 M   100.00% 0.33%
BIRCHVIEW CAPITAL, LP 02/13/2026 269.00 K $6.73 M   54.60% 0.31%
JPMORGAN CHASE & CO 02/11/2026 268.47 K $6.71 M   791.01% 0.31%
BANK OF AMERICA CORP /DE/ 02/17/2026 238.91 K $5.97 B   -70.22% 0.28%
NUVEEN, LLC 02/12/2026 229.47 K $5.74 M   78.97% 0.27%
SILVERARC CAPITAL MANAGEMENT, LLC 02/12/2026 206.28 K $5.16 M   -77.90% 0.24%
BANK OF NEW YORK MELLON CORP 02/10/2026 176.20 K $4.41 M   4.14% 0.21%
CITIGROUP INC 02/13/2026 147.36 K $3.68 M   620.74% 0.17%
PIER CAPITAL, LLC 02/03/2026 140.10 K $3.50 M   -73.28% 0.16%
TD ASSET MANAGEMENT INC 02/10/2026 136.40 K $3.41 M   100.00% 0.16%
BARCLAYS PLC 02/13/2026 133.13 K $3.33 M   27.24% 0.16%
CITADEL ADVISORS LLC 02/17/2026 104.80 K $2.62 B   100.00% 0.12%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 102.32 K $2.56 M   398.14% 0.12%
JUMP FINANCIAL, LLC 02/17/2026 100.27 K $2.51 M   100.00% 0.12%
AMERICAN CENTURY COMPANIES INC 02/13/2026 93.90 K $2.35 M   59.17% 0.11%
JANE STREET GROUP, LLC 02/12/2026 88.90 K $2.22 B   583.85% 0.10%
VICTORY CAPITAL MANAGEMENT INC 02/13/2026 86.10 K $2.15 M   -2.33% 0.10%
WELLS FARGO & COMPANY/MN 02/13/2026 84.13 K $2.10 M   84.25% 0.10%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 81.17 K $2.03 M   -0.02% 0.09%
RHUMBLINE ADVISERS 02/13/2026 74.38 K $1.86 B   -11.76% 0.09%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/12/2026 69.87 K $1.75 M   -88.73% 0.08%

Olema Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 157 institutional investors and hedge funds held shares of Olema Pharmaceuticals Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 5.56 M

VANGUARD GROUP INC: 3.56 M

Siren, L.L.C.: 3.3 M

Logos Global Management LP: 3.21 M

FRANKLIN RESOURCES INC: 2.48 M

STATE STREET CORP: 1.88 M

20.52% of Olema Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 42.49 M shares in the last 24 months. This purchase volume represents approximately $1.01 B in transactions.